Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and Bile Duct Cancer

9,10-dimethyl-1,2-benzanthracene has been researched along with Bile Duct Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berx, G; Declercq, W; Denecker, G; Devos, M; Gilbert, B; Haigh, J; Hochepied, T; Lambert, J; Lemeire, K; Leurs, K; Libbrecht, L; Lippens, S; Mc Guire, C; Van Den Broecke, C; Vandenabeele, P; Vuylsteke, M1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Bile Duct Cancer

ArticleYear
Elevated ΔNp63α Levels Facilitate Epidermal and Biliary Oncogenic Transformation.
    The Journal of investigative dermatology, 2017, Volume: 137, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bile Duct Neoplasms; Cell Transformation, Neoplastic; Cells, Cultured; Cellular Senescence; Hyperplasia; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phosphoproteins; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Trans-Activators

2017